English
简体中文
Total: £ 56.28
Published Date: 2025-06-23 | Pages: 141 | Tables: 137 | Medical Care
In 2024, the global market size of Pathological Examination was estimated to be worth US$ 34130 million and is forecast to reach approximately US$ 65910 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.
A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.
From perspective of type, pathological examination can be split into histopathology, cell pathology, immunohistochemical pathology and molecular pathology. In 2019, cell pathology took up for about 48% market share, which made it the largest segment of global pathological examination.
North America is the largest consumption region of pathological examination, with a consumption market share nearly 37% in 2019. The second place is Asia-Pacific; following North America with the consumption market share over 31% in 2020.
Key players of global pathological examination market are Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International. The top 5 players totally took up a market share of about 18% in 2019. Quest Diagnostics is in the first place, which accounted for above 5% of global market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pathological Examination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pathological Examination.
The Pathological Examination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pathological Examination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pathological Examination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Quest Diagnostics
Sonic Healthcare
Lab Corp
Unilabs
SYNLAB International
BML
Pathologists Diagnostic
StageBio
KingMed Diagnostics Group
Dian Diagnostics Group
Adicon Clinical Laboratories Inc.
Huayin Health
Segment by Type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Segment by Application
Hospital
Medical Laboratory
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Pathological Examination in global and regional level.
Chapter 3: Detailed analysis of Pathological Examination company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathological Examination revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Pathological Examination Product Introduction
1.2 Market by Type
1.2.1 Global Pathological Examination Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Histopathology
1.2.3 Cytopathology
1.2.4 Immunohistochemical Pathology
1.2.5 Molecular Pathology
1.3 Market by Application
1.3.1 Global Pathological Examination Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Medical Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pathological Examination Market Size Estimates and Forecasts
2.2 Pathological Examination Market Size by Region: 2024 Versus 2031
2.2.1 Global Pathological Examination Revenue by Region: 2020-2025
2.2.2 Global Pathological Examination Revenue Forecast by Region (2026-2031)
2.2.3 Global Pathological Examination Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Pathological Examination Revenue by Type (2020-2031)
3.1.2 Global Pathological Examination Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Pathological Examination Revenue by Application (2020-2031)
3.2.2 Global Pathological Examination Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Histopathology of Pathological Examination Revenue Market Share by Application
3.3.2 Cytopathology of Pathological Examination Revenue Market Share by Application
3.3.3 Immunohistochemical Pathology of Pathological Examination Revenue Market Share by Application
3.3.4 Molecular Pathology of Pathological Examination Revenue Market Share by Application
4 Global Pathological Examination by Company
4.1 Global Pathological Examination Revenue by Company (2020-2025)
4.2 Global Pathological Examination Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Pathological Examination Companies around the World: Ranking by Revenue
4.3.2 Global Pathological Examination Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Pathological Examination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Pathological Examination Companies Headquarters & Product Type
4.4.1 Global Pathological Examination Companies Headquarters
4.4.2 Date of International Companies Enter into Pathological Examination Market
4.4.3 Global Pathological Examination Companies Product & Service
4.4.4 Histopathology Revenue Market Share of Pathological Examination by Company
4.4.5 Cytopathology Revenue Market Share of Pathological Examination by Company
4.4.6 Immunohistochemical Pathology Revenue Market Share of Pathological Examination by Company
4.4.7 Molecular Pathology Revenue Market Share of Pathological Examination by Company
4.5 Global Pathological Examination Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Quest Diagnostics
5.1.1 Quest Diagnostics Corporation Information
5.1.2 Quest Diagnostics Description, Business Overview
5.1.3 Quest Diagnostics Pathological Examination Products Offered
5.1.4 Quest Diagnostics Pathological Examination Revenue and Gross Margin (2020-2025)
5.1.5 Quest Diagnostics Pathological Examination Revenue by Product in 2024
5.1.6 Quest Diagnostics Pathological Examination Revenue by Application in 2024
5.1.7 Quest Diagnostics Pathological Examination Revenue by Geographic Area in 2024
5.1.8 Quest Diagnostics Recent Developments
5.2 Sonic Healthcare
5.2.1 Sonic Healthcare Corporation Information
5.2.2 Sonic Healthcare Description, Business Overview
5.2.3 Sonic Healthcare Pathological Examination Products Offered
5.2.4 Sonic Healthcare Pathological Examination Revenue and Gross Margin (2020-2025)
5.2.5 Sonic Healthcare Pathological Examination Revenue by Product in 2024
5.2.6 Sonic Healthcare Pathological Examination Revenue by Application in 2024
5.2.7 Sonic Healthcare Pathological Examination Revenue by Geographic Area in 2024
5.2.8 Sonic Healthcare Recent Developments
5.3 Lab Corp
5.3.1 Lab Corp Corporation Information
5.3.2 Lab Corp Description, Business Overview
5.3.3 Lab Corp Pathological Examination Products Offered
5.3.4 Lab Corp Pathological Examination Revenue and Gross Margin (2020-2025)
5.3.5 Lab Corp Pathological Examination Revenue by Product in 2024
5.3.6 Lab Corp Pathological Examination Revenue by Application in 2024
5.3.7 Lab Corp Pathological Examination Revenue by Geographic Area in 2024
5.3.8 Lab Corp Recent Developments
5.4 Unilabs
5.4.1 Unilabs Corporation Information
5.4.2 Unilabs Description, Business Overview
5.4.3 Unilabs Pathological Examination Products Offered
5.4.4 Unilabs Pathological Examination Revenue and Gross Margin (2020-2025)
5.4.5 Unilabs Pathological Examination Revenue by Product in 2024
5.4.6 Unilabs Pathological Examination Revenue by Application in 2024
5.4.7 Unilabs Pathological Examination Revenue by Geographic Area in 2024
5.4.8 Unilabs Recent Developments
5.5 SYNLAB International
5.5.1 SYNLAB International Corporation Information
5.5.2 SYNLAB International Description, Business Overview
5.5.3 SYNLAB International Pathological Examination Products Offered
5.5.4 SYNLAB International Pathological Examination Revenue and Gross Margin (2020-2025)
5.5.5 SYNLAB International Pathological Examination Revenue by Product in 2024
5.5.6 SYNLAB International Pathological Examination Revenue by Application in 2024
5.5.7 SYNLAB International Pathological Examination Revenue by Geographic Area in 2024
5.5.8 SYNLAB International Recent Developments
5.6 BML
5.6.1 BML Corporation Information
5.6.2 BML Description, Business Overview
5.6.3 BML Pathological Examination Products Offered
5.6.4 BML Pathological Examination Revenue and Gross Margin (2020-2025)
5.6.5 BML Pathological Examination Revenue by Product in 2024
5.6.6 BML Pathological Examination Revenue by Application in 2024
5.6.7 BML Pathological Examination Revenue by Geographic Area in 2024
5.6.8 BML Recent Developments
5.7 Pathologists Diagnostic
5.7.1 Pathologists Diagnostic Corporation Information
5.7.2 Pathologists Diagnostic Description, Business Overview
5.7.3 Pathologists Diagnostic Pathological Examination Products Offered
5.7.4 Pathologists Diagnostic Pathological Examination Revenue and Gross Margin (2020-2025)
5.7.5 Pathologists Diagnostic Pathological Examination Revenue by Product in 2024
5.7.6 Pathologists Diagnostic Pathological Examination Revenue by Application in 2024
5.7.7 Pathologists Diagnostic Pathological Examination Revenue by Geographic Area in 2024
5.7.8 Pathologists Diagnostic Recent Developments
5.8 StageBio
5.8.1 StageBio Corporation Information
5.8.2 StageBio Description, Business Overview
5.8.3 StageBio Pathological Examination Products Offered
5.8.4 StageBio Pathological Examination Revenue and Gross Margin (2020-2025)
5.8.5 StageBio Pathological Examination Revenue by Product in 2024
5.8.6 StageBio Pathological Examination Revenue by Application in 2024
5.8.7 StageBio Pathological Examination Revenue by Geographic Area in 2024
5.8.8 StageBio Recent Developments
5.9 KingMed Diagnostics Group
5.9.1 KingMed Diagnostics Group Corporation Information
5.9.2 KingMed Diagnostics Group Description, Business Overview
5.9.3 KingMed Diagnostics Group Pathological Examination Products Offered
5.9.4 KingMed Diagnostics Group Pathological Examination Revenue and Gross Margin (2020-2025)
5.9.5 KingMed Diagnostics Group Pathological Examination Revenue by Product in 2024
5.9.6 KingMed Diagnostics Group Pathological Examination Revenue by Application in 2024
5.9.7 KingMed Diagnostics Group Pathological Examination Revenue by Geographic Area in 2024
5.9.8 KingMed Diagnostics Group Recent Developments
5.10 Dian Diagnostics Group
5.10.1 Dian Diagnostics Group Corporation Information
5.10.2 Dian Diagnostics Group Description, Business Overview
5.10.3 Dian Diagnostics Group Pathological Examination Products Offered
5.10.4 Dian Diagnostics Group Pathological Examination Revenue and Gross Margin (2020-2025)
5.10.5 Dian Diagnostics Group Pathological Examination Revenue by Product in 2024
5.10.6 Dian Diagnostics Group Pathological Examination Revenue by Application in 2024
5.10.7 Dian Diagnostics Group Pathological Examination Revenue by Geographic Area in 2024
5.10.8 Dian Diagnostics Group Recent Developments
5.11 Adicon Clinical Laboratories Inc.
5.11.1 Adicon Clinical Laboratories Inc. Corporation Information
5.11.2 Adicon Clinical Laboratories Inc. Description, Business Overview
5.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Products Offered
5.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Revenue and Gross Margin (2020-2025)
5.11.5 Adicon Clinical Laboratories Inc. Pathological Examination Revenue by Product in 2024
5.11.6 Adicon Clinical Laboratories Inc. Pathological Examination Revenue by Application in 2024
5.11.7 Adicon Clinical Laboratories Inc. Pathological Examination Revenue by Geographic Area in 2024
5.11.8 Adicon Clinical Laboratories Inc. Recent Developments
5.12 Huayin Health
5.12.1 Huayin Health Corporation Information
5.12.2 Huayin Health Description, Business Overview
5.12.3 Huayin Health Pathological Examination Products Offered
5.12.4 Huayin Health Pathological Examination Revenue and Gross Margin (2020-2025)
5.12.5 Huayin Health Pathological Examination Revenue by Product in 2024
5.12.6 Huayin Health Pathological Examination Revenue by Application in 2024
5.12.7 Huayin Health Pathological Examination Revenue by Geographic Area in 2024
5.12.8 Huayin Health Recent Developments
6 North America
6.1 North America Pathological Examination Market Size YoY Growth 2020-2031
6.2 North America Pathological Examination Market Facts & Figures by Country (2020-2031)
6.3 North America Pathological Examination Revenue by Type (2020-2025)
6.4 North America Pathological Examination Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Pathological Examination Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Pathological Examination Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Pathological Examination Revenue by Type (2020-2025)
7.4 Asia-Pacific Pathological Examination Revenue by Application (2020-2025)
8 Europe
8.1 Europe Pathological Examination Market Size YoY Growth 2020-2031
8.2 Europe Pathological Examination Market Facts & Figures by Country (2020-2031)
8.3 Europe Pathological Examination Revenue by Type (2020-2025)
8.4 Europe Pathological Examination Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Pathological Examination Market Size YoY Growth 2020-2031
9.2 Latin America Pathological Examination Market Facts & Figures by Country (2020-2031)
9.3 Latin America Pathological Examination Revenue by Type (2020-2025)
9.4 Latin America Pathological Examination Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Pathological Examination Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Pathological Examination Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Pathological Examination Revenue by Type (2020-2025)
10.4 Middle East and Africa Pathological Examination Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Pathological Examination Supply Chain Analysis
11.2 Pathological Examination Key Raw Materials and Upstream Suppliers
11.3 Pathological Examination Clients Analysis
11.4 Pathological Examination Sales Channel and Sales Model Analysis
11.4.1 Pathological Examination Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Pathological Examination Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Pathological Examination Distributors
12 Pathological Examination Market Dynamics
12.1 Pathological Examination Industry Trends
12.2 Pathological Examination Market Drivers
12.3 Pathological Examination Market Challenges
12.4 Pathological Examination Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Pathological Examination Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pathological Examination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Pathological Examination Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Pathological Examination Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pathological Examination Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Pathological Examination Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Pathological Examination Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 11. Pathological Examination Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Pathological Examination Players by Revenue (US$ Million) in 2024
Table 13. Global Pathological Examination Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Pathological Examination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
Table 15. Global Pathological Examination Companies Headquarters
Table 16. Date of International Companies Enter into Pathological Examination Market
Table 17. Global Pathological Examination Companies Product & Service
Table 18. Global Pathological Examination Mergers & Acquisitions, Expansion Plans
Table 19. Quest Diagnostics Corporation Information
Table 20. Quest Diagnostics Description and Business Overview
Table 21. Quest Diagnostics Pathological Examination Product
Table 22. Quest Diagnostics Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Quest Diagnostics Revenue Proportion of Pathological Examination by Product in 2024
Table 24. Quest Diagnostics Revenue Proportion of Pathological Examination by Application in 2024
Table 25. Quest Diagnostics Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 26. Quest Diagnostics Recent Developments
Table 27. Sonic Healthcare Corporation Information
Table 28. Sonic Healthcare Description and Business Overview
Table 29. Sonic Healthcare Pathological Examination Product
Table 30. Sonic Healthcare Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Sonic Healthcare Revenue Proportion of Pathological Examination by Product in 2024
Table 32. Sonic Healthcare Revenue Proportion of Pathological Examination by Application in 2024
Table 33. Sonic Healthcare Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 34. Sonic Healthcare Recent Developments
Table 35. Lab Corp Corporation Information
Table 36. Lab Corp Description and Business Overview
Table 37. Lab Corp Pathological Examination Product
Table 38. Lab Corp Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Lab Corp Revenue Proportion of Pathological Examination by Product in 2024
Table 40. Lab Corp Revenue Proportion of Pathological Examination by Application in 2024
Table 41. Lab Corp Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 42. Lab Corp Recent Developments
Table 43. Unilabs Corporation Information
Table 44. Unilabs Description and Business Overview
Table 45. Unilabs Pathological Examination Product
Table 46. Unilabs Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Unilabs Revenue Proportion of Pathological Examination by Product in 2024
Table 48. Unilabs Revenue Proportion of Pathological Examination by Application in 2024
Table 49. Unilabs Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 50. Unilabs Recent Developments
Table 51. SYNLAB International Corporation Information
Table 52. SYNLAB International Description and Business Overview
Table 53. SYNLAB International Pathological Examination Product
Table 54. SYNLAB International Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. SYNLAB International Revenue Proportion of Pathological Examination by Product in 2024
Table 56. SYNLAB International Revenue Proportion of Pathological Examination by Application in 2024
Table 57. SYNLAB International Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 58. SYNLAB International Recent Developments
Table 59. BML Corporation Information
Table 60. BML Description and Business Overview
Table 61. BML Pathological Examination Product
Table 62. BML Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. BML Revenue Proportion of Pathological Examination by Product in 2024
Table 64. BML Revenue Proportion of Pathological Examination by Application in 2024
Table 65. BML Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 66. BML Recent Developments
Table 67. Pathologists Diagnostic Corporation Information
Table 68. Pathologists Diagnostic Description and Business Overview
Table 69. Pathologists Diagnostic Pathological Examination Product
Table 70. Pathologists Diagnostic Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Pathologists Diagnostic Revenue Proportion of Pathological Examination by Product in 2024
Table 72. Pathologists Diagnostic Revenue Proportion of Pathological Examination by Application in 2024
Table 73. Pathologists Diagnostic Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 74. Pathologists Diagnostic Recent Developments
Table 75. StageBio Corporation Information
Table 76. StageBio Description and Business Overview
Table 77. StageBio Pathological Examination Product
Table 78. StageBio Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. StageBio Revenue Proportion of Pathological Examination by Product in 2024
Table 80. StageBio Revenue Proportion of Pathological Examination by Application in 2024
Table 81. StageBio Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 82. StageBio Recent Developments
Table 83. KingMed Diagnostics Group Corporation Information
Table 84. KingMed Diagnostics Group Description and Business Overview
Table 85. KingMed Diagnostics Group Pathological Examination Product
Table 86. KingMed Diagnostics Group Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. KingMed Diagnostics Group Revenue Proportion of Pathological Examination by Product in 2024
Table 88. KingMed Diagnostics Group Revenue Proportion of Pathological Examination by Application in 2024
Table 89. KingMed Diagnostics Group Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 90. KingMed Diagnostics Group Recent Developments
Table 91. Dian Diagnostics Group Corporation Information
Table 92. Dian Diagnostics Group Description and Business Overview
Table 93. Dian Diagnostics Group Pathological Examination Product
Table 94. Dian Diagnostics Group Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Dian Diagnostics Group Revenue Proportion of Pathological Examination by Product in 2024
Table 96. Dian Diagnostics Group Revenue Proportion of Pathological Examination by Application in 2024
Table 97. Dian Diagnostics Group Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 98. Dian Diagnostics Group Recent Developments
Table 99. Adicon Clinical Laboratories Inc. Corporation Information
Table 100. Adicon Clinical Laboratories Inc. Description and Business Overview
Table 101. Adicon Clinical Laboratories Inc. Pathological Examination Product
Table 102. Adicon Clinical Laboratories Inc. Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Adicon Clinical Laboratories Inc. Revenue Proportion of Pathological Examination by Product in 2024
Table 104. Adicon Clinical Laboratories Inc. Revenue Proportion of Pathological Examination by Application in 2024
Table 105. Adicon Clinical Laboratories Inc. Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 106. Adicon Clinical Laboratories Inc. Recent Developments
Table 107. Huayin Health Corporation Information
Table 108. Huayin Health Description and Business Overview
Table 109. Huayin Health Pathological Examination Product
Table 110. Huayin Health Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Huayin Health Revenue Proportion of Pathological Examination by Product in 2024
Table 112. Huayin Health Revenue Proportion of Pathological Examination by Application in 2024
Table 113. Huayin Health Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 114. Huayin Health Recent Developments
Table 115. North America Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Pathological Examination Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Pathological Examination Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 135. Pathological Examination Key Raw Materials, Industry Status and Trend
Table 136. Pathological Examination Key Raw Materials and Upstream Suppliers
Table 137. Pathological Examination Clients Status and Trend
Table 138. Pathological Examination Typical Clients
Table 139. Pathological Examination Distributors
Table 140. Pathological Examination Market Trends
Table 141. Pathological Examination Market Drivers
Table 142. Pathological Examination Market Challenges
Table 143. Pathological Examination Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pathological Examination Product Picture
Figure 2. Global Pathological Examination Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Pathological Examination Revenue Market Share by Type in 2024 & 2031
Figure 4. Histopathology Product Picture
Figure 5. Cytopathology Product Picture
Figure 6. Immunohistochemical Pathology Product Picture
Figure 7. Molecular Pathology Product Picture
Figure 8. Global Pathological Examination Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Pathological Examination Revenue Market Share by Application in 2024 & 2031
Figure 10. Hospital
Figure 11. Medical Laboratory
Figure 12. Pathological Examination Report Years Considered
Figure 13. Global Pathological Examination Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pathological Examination Market Size (2020-2031) & (US$ Million)
Figure 15. Global Pathological Examination Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Pathological Examination Revenue Market Share by Region (2020-2031)
Figure 17. Global Pathological Examination Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Pathological Examination Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Histopathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 20. Cytopathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 21. Immunohistochemical Pathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 22. Molecular Pathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 23. Pathological Examination Revenue Share by Company (2024)
Figure 24. Pathological Examination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Histopathology Revenue Proportion by Company in 2024
Figure 26. Cytopathology Revenue Proportion by Company in 2024
Figure 27. Immunohistochemical Pathology Revenue Proportion by Company in 2024
Figure 28. Molecular Pathology Revenue Proportion by Company in 2024
Figure 29. North America Pathological Examination Revenue 2020-2031 (US$ Million)
Figure 30. North America Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 31. North America Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Pathological Examination Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Pathological Examination Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 36. Europe Pathological Examination Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Pathological Examination Revenue Market Share by Country (2020-2031)
Figure 38. Europe Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 39. Europe Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Pathological Examination Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Pathological Examination Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Pathological Examination Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Pathological Examination Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 48. Pathological Examination Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Pathological Examination Raw Materials by Region in 2024
Figure 50. Pathological Examination Distribution Channels
Figure 51. Global Pathological Examination Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Pathological Examination Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
